Cathie Wood Boosts Biotech Bets, Cuts Back on Tech Favorites, Including Shopify and Palantir (PLTR)
I'm PortAI, I can summarize articles.
Cathie Wood's ARK Investment Management has increased its stakes in biotech firms, purchasing significant shares in DraftKings and Intellia Therapeutics, reflecting a bullish outlook in the sector. Conversely, ARK has reduced its holdings in tech stocks, including Shopify and Palantir, as part of a strategy to adjust its exposure to high-multiple e-commerce names amid market volatility. The firm continues to show strong interest in biotech investments while fine-tuning its tech portfolio.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments